Telomir Pharmaceuticals, Inc.
TELO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001971532
No open-market purchases or sales by Telomir Pharmaceuticals, Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $3.80M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Telomir Pharmaceuticals, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- +18 vs. Q1 2024
- Shares held
- 361.5K
- +281.6K (+352.3%) vs. Q1 2024
- Total value
- $1.74M
- +$1.33M (+320.5%) vs. Q1 2024
- New holders
- 20
- 2 more added
- Sold out
- 2
- 2 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TELO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 33 | $3.80M |
| Q1 2026 | 27 | $2.91M |
| Q4 2025 | 33 | $3.04M |
| Q3 2025 | 32 | $3.24M |
| Q2 2025 | 43 | $3.51M |
| Q1 2025 | 42 | $11.9M |
| Q4 2024 | 39 | $14.7M |
| Q3 2024 | 34 | $13.1M |
| Q2 2024 | 25 | $1.74M |
| Q1 2024 | 7 | $413.5K |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Telomir Pharmaceuticals, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock Inc. | 87,899 | $422.8K | 0.00% | +87,899 | New |
| Geode Capital Management, LLC | 66,355 | $319.2K | 0.00% | +66,355 | New |
| Bank of New York Mellon Corp | 50,165 | $241.3K | 0.00% | +50,165 | New |
| Vanguard Group Inc | 28,680 | $138.0K | 0.00% | +28,680 | New |
| Suncoast Equity Management | 24,391 | $117.3K | 0.01% | 00.0% | Unchanged |
| New York State Common Retirement Fund | 23,400 | $112.6K | 0.00% | +23,400 | New |
| State Street Corp | 18,127 | $87.2K | 0.00% | +18,127 | New |
| Beaird Harris Wealth Management, LLC | 14,623 | $70.3K | 0.01% | +9,950+212.9% | Added |
| Charles Schwab Investment Management Inc | 10,850 | $52.2K | 0.00% | +10,850 | New |
| Citigroup Inc | 6,554 | $31.5K | 0.00% | −11,194−63.1% | Reduced |
| UBS Group AG | 5,931 | $28.5K | 0.00% | +5,931 | New |
| Morgan Stanley | 5,199 | $25.0K | 0.00% | +5,199 | New |
| Rhumbline Advisers | 5,062 | $24.3K | 0.00% | +5,062 | New |
| Corebridge Financial, Inc. | 2,588 | $12.5K | 0.00% | +2,588 | New |
| Bank of America Corp | 2,390 | $11.5K | 0.00% | +2,390 | New |
| JPMorgan Chase & Co | 2,050 | $9.86K | 0.00% | −555−21.3% | Reduced |
| Wells Fargo & Company | 1,790 | $8.61K | 0.00% | +1,790 | New |
| Barclays PLC | 1,651 | $7.94K | 0.00% | +1,651 | New |
| Advisor Group Holdings, Inc. | 1,000 | $4.81K | 0.00% | +400+66.7% | Added |
| Tower Research Capital LLC (TRC) | 948 | $4.56K | 0.00% | +948 | New |
| Ameritas Investment Partners, Inc. | 471 | $2.27K | 0.00% | +471 | New |
| Royal Bank of Canada | 453 | $2.00K | 0.00% | +453 | New |
| BNP Paribas Arbitrage, SA | 400 | $1.92K | 0.00% | +400 | New |
| California State Teachers Retirement System | 349 | $1.68K | 0.00% | +349 | New |
| Amalgamated Bank | 166 | $1.00K | 0.00% | +166 | New |
| Lido Advisors, LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −14,900−100.0% | Sold out |